Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brain.

Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brain.

The development of pharmacological magnetic resonance imaging (phMRI) has presented the opportunity for investigation of the neurophysiological effects of drugs in vivo. Psilocin, a hallucinogen metabolised from psilocybin, was recently reported to evoke brain region-specific, phMRI signal changes i...

Full description

Bibliographic Details
Main Authors:	Spain, A, Howarth, C, Khrapitchev, A, Sharp, T, Sibson, N, Martin, C
Format:	Journal article
Language:	English
Published:	Elsevier 2015

Similar Items

Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory mice
by: Thomas, CW, et al.
Published: (2022)

The effect of psilocin on memory acquisition, retrieval and consolidation in rat.
by: Lukas eRambousek, et al.
Published: (2014-05-01)

Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory mice
by: Christopher W. Thomas, et al.
Published: (2022-02-01)

Corrigendum to "Systemic inflammation alters central 5-HT function as determined by pharmacological MRI" [Neuroimage 75 (2013) 177-186]
by: Couch, Y, et al.
Published: (2014)

Is Shame Hallucinogenic?
by: Simon McCarthy-Jones
Published: (2017-08-01)

Associations between individual hallucinogens and hallucinogen misuse among U.S. Adults who recently initiated hallucinogen use
by: Grant Jones, et al.
Published: (2023-12-01)

Psylocybin and Psilocin as new tools to fight depression
by: Sofia Lemos Martins, et al.
Published: (2022-04-01)

STAT3-mediated astrocyte reactivity associated with brain metastasis contributes to neurovascular dysfunction
by: Sarmiento Soto, M, et al.
Published: (2020)

Underlying pharmacological mechanisms of psilocin-induced broadband desynchronization and disconnection of EEG in rats
by: Filip Tylš, et al.
Published: (2023-06-01)

GLP-1 Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight
by: Giulia Monti, et al.
Published: (2022-06-01)

Regional differences in neurovascular coupling in rat brain as determined by fMRI and electrophysiology.
by: Sloan, H, et al.
Published: (2010)

The Theoretical Description for Psilocin Electrochemical Determination over Cobalt Oxyhydroxide
by: Volodymyr Tkach, et al.
Published: (2023-04-01)

Production and extraction of psilocybin and psilocin from Psilocybe spp. mushrooms
by: Joana Margarida Costa Fernandes, et al.
Published: (2022-04-01)

Neuroimaging of animal models of brain disease.
by: Lythgoe, M, et al.
Published: (2003)

Serotonin 2C receptor agonists and the behavioural satiety sequence in mice.
by: Hewitt, K, et al.
Published: (2002)

CROSS-SPECIES EVIDENCE FOR PSILOCIN-INDUCED VISUAL HALLUCINATIONS: RATS PERCEIVE QUALITATIVELY SIMILAR CHANGES AS HUMANS
by: Cestmir Vejmola, et al.
Published: (2023-10-01)

Mechanistic pathways underlying altered neurovascular coupling in brain metastasis
by: Sarmiento Soto, M, et al.
Published: (2016)

Salvinorin A, a kappa-opioid receptor (KOP-r) agonist hallucinogen: Pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders
by: Eduardo eButelman, et al.
Published: (2015-09-01)

Affinity of (+/-)-pindolol, (-)-penbutolol, and (-)-tertatolol for pre- and postsynaptic serotonin 5-HT(1A) receptors in human and rat brain.
by: Castro, M, et al.
Published: (2000)

Hallucinogens : a forensic drug handbook /
by: Laing, Richard R., et al.
Published: (2003)

Effects of hallucinogenic drugs on the human heart
by: Joachim Neumann, et al.
Published: (2024-02-01)

Psychedelic medicine and the clinical application of hallucinogens
by: eClinicalMedicine
Published: (2023-02-01)

Human biodistribution and dosimetry of ¹¹C-CUMI-101, an agonist radioligand for serotonin-1a receptors in brain.
by: Christina S Hines, et al.
Published: (2011-01-01)

Whole-brain multimodal neuroimaging model using serotonin receptor maps explains non-linear functional effects of LSD
by: Deco, G, et al.
Published: (2018)

Serotonin receptor agonists in the acute treatment of migraine: a review on their therapeutic potential
by: Negro A, et al.
Published: (2018-03-01)

Evaluation of a quantitative analytical method for psilocin and psilocybin using HPLC-DAD
by: Cesar Filho, et al.
Published: (2022-04-01)

Retinal Neuroprotective Effects of Flibanserin, an FDA-Approved Dual Serotonin Receptor Agonist-Antagonist.
by: Aaron S Coyner, et al.
Published: (2016-01-01)

Hallucinogens/psychedelics resurrected as new tools in psychiatric therapy
by: Rafael G. dos Santos, et al.

A Review of Aeruginascin and Potential Entourage Effect in Hallucinogenic Mushrooms
by: P. Chue, et al.
Published: (2022-06-01)

The Potential Role of Serotonergic Hallucinogens in Depression Treatment
by: Dominika Psiuk, et al.
Published: (2021-07-01)

Dimethyltryptamine: hallucinogenic alkaloid on the Central Nervous System
by: Darliane Freire Almeida, et al.
Published: (2018-01-01)

Hallucinogenic drugs in pre-Columbian Mesoamerican cultures
by: F.J. Carod-Artal
Published: (2015-01-01)

Brain Networks Implicated in Seasonal Affective Disorder: A Neuroimaging PET Study of the Serotonin Transporter
by: Martin Nørgaard, et al.
Published: (2017-11-01)

Psilocybin modulation of time-varying functional connectivity is associated with plasma psilocin and subjective effects
by: Anders S. Olsen, et al.
Published: (2022-12-01)

Psilacetin derivatives: fumarate salts of the methyl–ethyl, methyl–allyl and diallyl variants of the psilocin prodrug
by: Duyen N. K. Pham, et al.
Published: (2021-02-01)

Structural and functional effects of metastases in rat brain determined by multimodal MRI.
by: Serres, S, et al.
Published: (2014)

Efficacy of serotonin receptor agonists in the treatment of functional dyspepsia: a meta-analysis
by: Man Jin, et al.
Published: (2018-12-01)

In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin
by: Nathan T. Jones, et al.
Published: (2024-01-01)

Neurotoxicological profile of the hallucinogenic compound 25I-NBOMe
by: Monika Herian, et al.
Published: (2022-02-01)

Research on Acute Toxicity and the Behavioral Effects of Methanolic Extract from Psilocybin Mushrooms and Psilocin in Mice
by: Olga Zhuk, et al.
Published: (2015-03-01)